Antenatal toxoplasmosis screening found ineffective
This article was originally published in Clinica
Executive Summary
Antenatal screening for congenital toxoplasmosis is based on poor evidence and is not cost-effective in low-risk countries, according to two research papers. These reviewed the benefits of the national antenatal screening programme for toxoplasmosis in France and considered the introduction of such a programme in Denmark.